The latest signs of the consumer health product sector’s interest in driving sales through marketing to consumers using GLP-1 drugs for weight loss suggest the size of the opportunity.
US Consumer Health Sector Seizing Opportunity To Market Products, Services To GLP-1 Patients
Latest moves on selling to consumers using GLP-1 receptor agonist drugs for obesity come from firms as large as global food products manufacturer and marketer Nestle and as small as startup Promino and as ambitious as men’s health product marketer Ro offering an app at no charge to find GLP-1 drugs.
